Vedolizumab trials for Ulcerative Colitis (UC)

All Vedolizumab trials · All Ulcerative Colitis (UC) trials

Phase breakdown

Recruiting trials studying Vedolizumab for Ulcerative Colitis (UC)

• Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
  NCT06095596 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
  NCT07442045 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
  NCT06850727 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 32 locations

Common questions

How many trials study Vedolizumab for Ulcerative Colitis (UC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.